FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387393000: Pemoline (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461571018 Pemoline (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481487013 Pemoline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492039010 Phenylisohydantoin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492040012 PIO en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
831811000172118 pémoline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pemoline (substance) Is a Central stimulant (substance) true Inferred relationship Some
Pemoline (substance) Is a classe d'allergènes false Inferred relationship Some
Pemoline (substance) Is a allergène médicamenteux false Inferred relationship Some
Pemoline (substance) Is a Azole true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Pemoline measurement Component True Pemoline (substance) Inferred relationship Some 1
Pemoline adverse reaction Causative agent (attribute) True Pemoline (substance) Inferred relationship Some 1
Allergy to pemoline (finding) Causative agent (attribute) False Pemoline (substance) Inferred relationship Some
Pemoline 18.75 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some
Pemoline 37.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some
Pemoline 75 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some
Product containing pemoline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 1
Product containing methyltestosterone and pemoline and yohimbine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 2
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some
Allergy to pemoline (finding) Causative agent (attribute) True Pemoline (substance) Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Pemoline (substance) Inferred relationship Some 1
Pemoline 18.75 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some 1
Pemoline 18.75 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pemoline (substance) Inferred relationship Some 1
Pemoline 37.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some 1
Pemoline 37.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pemoline (substance) Inferred relationship Some 1
Pemoline 75 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pemoline (substance) Inferred relationship Some 1
Pemoline 75 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pemoline (substance) Inferred relationship Some 1
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pemoline (substance) Inferred relationship Some 2
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pemoline (substance) Inferred relationship Some 2
Pemoline 18.75 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pemoline (substance) Inferred relationship Some 1
Pemoline 37.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pemoline (substance) Inferred relationship Some 1
Pemoline 75 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pemoline (substance) Inferred relationship Some 1
Methyltestosterone- and pemoline- and yohimbine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 2
Product containing pemoline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 1
Product containing only methyltestosterone and pemoline and yohimbine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 2
Pemoline only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 1
Methyltestosterone and pemoline and yohimbine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 2
Pemoline only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pemoline (substance) Inferred relationship Some 1
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pemoline (substance) Inferred relationship Some 1
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pemoline (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start